Correlation Between 89bio and Fate Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 89bio and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 89bio and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 89bio Inc and Fate Therapeutics, you can compare the effects of market volatilities on 89bio and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 89bio with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 89bio and Fate Therapeutics.

Diversification Opportunities for 89bio and Fate Therapeutics

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between 89bio and Fate is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding 89bio Inc and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and 89bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 89bio Inc are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of 89bio i.e., 89bio and Fate Therapeutics go up and down completely randomly.

Pair Corralation between 89bio and Fate Therapeutics

Given the investment horizon of 90 days 89bio Inc is expected to generate 0.86 times more return on investment than Fate Therapeutics. However, 89bio Inc is 1.16 times less risky than Fate Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  1,276  in 89bio Inc on November 28, 2024 and sell it today you would lose (359.00) from holding 89bio Inc or give up 28.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

89bio Inc  vs.  Fate Therapeutics

 Performance 
       Timeline  
89bio Inc 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in 89bio Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, 89bio sustained solid returns over the last few months and may actually be approaching a breakup point.
Fate Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

89bio and Fate Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 89bio and Fate Therapeutics

The main advantage of trading using opposite 89bio and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 89bio position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.
The idea behind 89bio Inc and Fate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios